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Catch-bond mechanism of the bacterial
adhesin FimH
Maximilian M. Sauer1,*, Roman P. Jakob2,*, Jonathan Eras1, Sefer Baday2,3, Deniz Eris¸4, Giulio Navarra4,
Simon Berne`che2,3, Beat Ernst4, Timm Maier2 & Rudi Glockshuber1
Ligand–receptor interactions that are reinforced by mechanical stress, so-called catch-bonds,
play a major role in cell–cell adhesion. They critically contribute to widespread urinary tract
infections by pathogenic Escherichia coli strains. These pathogens attach to host epithelia
via the adhesin FimH, a two-domain protein at the tip of type I pili recognizing terminal
mannoses on epithelial glycoproteins. Here we establish peptide-complemented FimH
as a model system for fimbrial FimH function. We reveal a three-state mechanism of FimH
catch-bond formation based on crystal structures of all states, kinetic analysis of ligand
interaction and molecular dynamics simulations. In the absence of tensile force, the FimH
pilin domain allosterically accelerates spontaneous ligand dissociation from the FimH lectin
domain by 100,000-fold, resulting in weak affinity. Separation of the FimH domains under
stress abolishes allosteric interplay and increases the affinity of the lectin domain. Cell
tracking demonstrates that rapid ligand dissociation from FimH supports motility of piliated
E. coli on mannosylated surfaces in the absence of shear force.
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C
ell–cell adhesion often occurs under dynamically varying
conditions and mechanical stress. In many cell–cell
adhesion systems, the lifetime of adhesin–receptor
complexes is increased under tensile mechanical force via
‘catch-bonds’, which permit capture or retention of cells under
flow conditions while still allowing for release under reduced
mechanical force. Catch-bond interactions are prominent in
vascular systems and are formed, for example, by selectins for
leukocyte recruitment1,2, by cadherins controlling tissue
integrity3,4 in the epithelial adhesion of cancer cells5 and by the
interactions between T-cell receptors (TCRs) and peptide-bound
major histocompatibility complexes (MHC) on antigen-
presenting cells6,7. Catch-bonds also play a major role in
bacterial adhesion and infection by uropathogenic Escherichia
coli strains, which are responsible for the vast majority of urinary
tract infections (UTIs) in humans8. A first critical step in the
establishment of infection is bacterial adhesion to urothelial cells
under flow conditions, which is mediated by 0.1 2 mm long,
proteinaceous filaments on the bacterial surface termed type 1
pili9,10. Type 1 pili are composed of up to 3,000 copies of the
subunit FimA building the pilus rod, as well as the subunits FimF,
FimG and FimH forming the distal tip fibrillum11. The adhesin
FimH at the fimbrial tip specifically binds in a catch-bond mode12
to terminal a-D-linked mannoses of N-linked glycans of the
receptor uroplakin 1a on urinary epithelial cells13. Owing to its
important role in establishing infection, FimH is an attractive
target for the development of anti-adhesive drugs for UTI
treatment14,15.
FimH is a two-domain protein, composed of an N-terminal,
mannoside-binding lectin domain (FimHL) and a C-terminal
pilin domain (FimHP). FimHP possesses an incomplete
immunoglobulin-like fold that is completed by insertion of an
N-terminal donor strand of FimG, the subsequent subunit in
pilus assembly11. The two-domain architecture of FimH is a
prerequisite for catch-bond formation because the interactions
between FimHL and FimHP determine the conformational state
and ligand-binding properties of FimHL (refs 12,16,17).
A ‘compressed’ FimHL conformation was observed in the
crystal structure of FimH in the context of the type 1 pilus tip
fibrillum in the absence of ligands, with an open binding site and
interactions to FimHP mediated via three loop segments: the
swing (amino acids (aa.) 27–33), linker (aa. 154–160) and
insertion loops (aa. 112–118)17. In contrast, an ‘extended’ FimHL
conformation was observed in crystal structures of the isolated,
ligand-bound FimHL domain18–23 and in the complex between
FimH and the pilus assembly chaperone FimC, where FimC
prevents the interactions between FimHL and FimHP (ref. 24).
This extended form of FimHL is characterized by a closed ligand-
binding pocket and rearranged swing, linker and insertion loops.
Notably, isolated FimHL was reported to show a ligand-binding
affinity about two orders of magnitude higher than that of full-
length FimH in the tip fibrillum17,25. Together with mutagenesis
experiments disrupting the interdomain interface26, these data
indicated that ligand-binding is linked to domain separation in
FimH, and that mechanical force shifts the ligand-binding affinity
towards that of the isolated FimHL. However, fundamental
aspects of the mechanism underlying the force-dependent
binding of FimH remained unknown: (i) How is domain-
associated, full-length FimH interacting with ligands? (ii) Does
ligand-binding directly induce domain separation? (iii) How are
interdomain interactions linked to the ligand-binding affinity of
FimH and the kinetics of ligand-binding and dissociation?
To address these questions, we designed a stable, soluble
variant of full-length FimH that is equivalent in its structural and
functional properties to those of FimH in the assembled fimbrial
tip. This variant allowed us to obtain high-resolution structural
snapshots of all functional states of FimH and to obtain a
complete characterization of ligand-binding kinetics in solution.
Together with molecular dynamics simulations, these data reveal
a three-state mechanism of FimH catch-bond formation. FimHP
accelerates ligand release from FimHL via dynamic allostery by
100,000-fold. In addition, using single-cell tracking experiments,
we show that the modulation of ligand affinity by FimHP is not
only required for adhesion under mechanical stress, but also for
efficient bacterial surface motility in the absence of shear force.
Our results provide a first complete structural and kinetic
description of a catch-bond system and establish a framework for
the analysis of the distinct catch-bond mechanisms in other
systems, which also commonly couple interdomain interactions
to ligand affinity.
Results
Construction of a peptide-complemented FimH. Isolated FimH
with its non-complemented pilin domain is only marginally
stable and shows aggregation tendency under physiological con-
ditions27. To establish a stable, isolated FimH molecule with all
properties of FimH in the tip fibrillum, we complemented FimHP
with the donor-strand peptide of FimG (FimG residues 1 14;
termed DsG). The FimH DsG complex was obtained in good
yields and purified after an in vitro reaction, mimicking the first
donor-strand exchange (DSE) reaction during pilus assembly
in vivo. In this reaction, the FimG donor strand displaces the pilus
assembly chaperone FimC from FimH (Fig. 1a):
FimC  FimHþDsG!kDSE FimH  DsGþ FimC
pH 7:0; 37 C; kDSE  0:5M 1s 1
  ð1Þ
The experiments described in the following were performed
with FimH from the faecal E. coli strain F18 (FimHF18), which
is structurally identical to the most prevalent variants in
uropathogenic infection25, and FimH from the wild-type E. coli
strain K12 (FimHK12), which differ in three amino acids in
FimHL (K12-F18: Val27Ala, Asn70Ser, Ser78Asn; Supplementary
Fig. 1a). The isolated lectin domains (residues 1–159) of both
FimH variants (FimHLK12 and FimHLF18) were produced by direct
expression in the E. coli periplasm and were purified as
described27.
Ligand-free FimH .DsG resembles FimH in the fimbrial tip.
The crystal structure of the binary complex FimHF18 DsG was
determined at atomic resolution by molecular replacement
(Table 1). FimHF18 DsG comprises the jellyroll fold FimHL and
the immunoglobulin-like FimHP domain complemented with the
FimG donor strand (Fig. 1b and Supplementary Fig. 1b). It closely
resembles unliganded FimH in the fimbrial tip complex
(Fig. 1c)17, with a root-mean-square deviation of Ca positions (Ca
r.m.s.d.) of 1.1 Å. The individual FimHP and FimHL domains are
even more closely resembling unliganded, fimbrial FimH (r.m.s.d.
0.45 and 0.55Å, respectively) and undergo only a minimal hinge-
bending rotation of 4 (Fig. 1c).
The DsG peptide in FimHF18 DsG is in identical position as
compared with the N-terminal FimG extension in the fimbrial tip
structure; it interacts with b-strand 2 and 9 of FimHP (Fig. 1d).
All contacts in the FimHL–FimHP interdomain region
(Supplementary Fig. 1c,d)17 as well as the conformation of the
empty ligand-binding pocket observed in FimH in the fimbrial tip
are preserved in FimHF18 DsG. Thus, FimHF18 DsG represents
the ligand-free state of fimbrial FimH, with Associated FimHL
and FimHP (Afree state) and is an elegant minimal system to
analyse the crosstalk between ligand-binding and interdomain
interactions underlying the formation of catch-bonds by FimH.
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Persistence of domain association in ligand-bound FimH .DsG.
To test whether ligand-binding causes domain separation in FimH,
we determined the co-crystal structure of the ternary complex of
FimHF18 DsG with n-heptyl a-D-mannoside (HM), an established
model ligand of FimH20, as well as crystal structures of the isolated
FimHLF18 and FimHLK12 lectin domains in complex with HM
(Table 1). FimHF18 DsG HM adopts the same closed conformation
of the ligand-binding site as previously observed in other FimHL–
ligand complexes (Fig. 2a,b and Supplementary Fig. 2)28. The
mannopyranose moiety of HM is coordinated by the side chains of
Asp54, Gln133, Asn135 and Asp140, and the main chain of Phe1
and Asp47, and the n-heptyl aglycone of HM is sandwiched
between Tyr48 and Tyr137. Compared with the Afree form, all
loops surrounding the binding pocket close down onto the HM
ligand. The most substantial conformational difference to Afree is
observed for the clamp loop (aa. 8–16), whose tip moves almost 6Å
towards HM (Supplementary Fig. 1e,f).
Besides the closing of the ligand-binding pocket, the overall
conformation of ligand-free FimHL in Afree and HM-bound
FimHF18 DsG is closely similar (Ca r.m.s.d. 1.1 Å; Fig. 2a,b and
Supplementary Fig. 2). Unexpectedly, the structural change in the
ligand-binding site in FimHF18 DsG HM was not transmitted to
the domain interface, where the interdomain contacts and the
conformations of the swing, linker and insertion loops remained
intact. The lectin domain in the FimHF18 DsG HM complex
thus differs drastically from HM-bound isolated FimHL domains
with respect to the swing, linker and insertion loop conforma-
tions (Fig. 2c). On the basis of the persistence of the domain
Association in the ligand-bound form, this state of FimH was
termed Abound.
To test the stability of the Abound state against domain
separation and to exclude potential effects of selective crystal-
lization, a molecular dynamics (MD) simulation of the Abound
state was conducted using the CHARMM36 force field of the
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Figure 1 | FimH .DsG resembles fimbrial tip FimH. (a) Preparation of the FimH DsG complex by DSE. Left: reaction scheme of the DSE reaction, in which
DsG displaces the FimC chaperone from the FimH pilin domain. Right: kinetics of the FimH DsG complex formation at 37 C, monitored by analytical gel
filtration. DSE was initiated by mixing the FimC  FimH complex (15mM) with excess DsG peptide (50mM). Samples were removed after different
incubation times, rapidly cooled on ice and immediately subjected to gel filtration. The reaction can be followed by the decrease in the FimC  FimH complex
concentration and the simultaneous increase in the concentrations of FimH DsG and free FimC (FimC and FimH DsG coelute as a single peak atB12ml).
The chromatogram at the bottom shows that the FimC  FimH complex is stable against dissociation/aggregation under the chosen conditions. The rate
constant of DSE estimated from these data is B0.5M 1 s 1. (b) Structure of FimHF18 DsG (lectin domain FimHL, red; pilin domain FimHP, yellow;
DsG, blue; circle and square indicate N- and C termini, respectively). (c) FimH from the fimbrial tip structure (left, PDB ID: 3JWN (ref. 17); FimG, blue;
FimF, green) is superposed onto FimHF18 DsG based on their pilin domains (aa. 160–279), in the superposition (right) fimbrial FimH is shown in grey.
(d) Close-up on the DsG peptide (stick representation) bound to FimHF18 DsG with 2Fo–Fc electron density map. Backbone hydrogen bonds of the DsG
peptide and b-strands 2 (b2) and 9 (b9) of FimHP are indicated.
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NAMD package (Supplementary Fig. 3a,b). The domain associa-
tion remained intact over 100 ns of simulation time without
substantial changes in the domain interface; fluctuations were
limited to the clamp loop region close to the ligand-binding site.
On in silico removal of the HM ligand after initial equilibration,
the Abound state underwent a spontaneous transition to the Afree
state afterB75 ns of simulation time via an opening of the clamp
loop (Supplementary Fig. 3c,d), reproducing the experimentally
observed dependence of the binding-site conformation on ligand-
binding. Thus, the MD simulations indicate that Abound is a stable
conformational state of FimH induced by ligand-binding.
Trapping of a domain-separated state of full-length FimH. The
increase in apparent affinity of FimH to its target glycans under
tensile mechanical forces12,29 has previously been linked to a
separation of the FimHL and FimHP (ref. 17). To trap a potential
domain-separated state of FimH for structural characterization in
the absence of tensile force, we considered FimH variants with
weakened interdomain interactions. We had shown previously
that FimHP also accepts the donor strand of the non-cognate
subunit FimF (DsF). However, FimHP is slightly less stabilized by
complementation with DsF than with the natural donor-strand
DsG30. We hypothesized that such complementation with DsF
instead of DsG could also result in a mild destabilization of the
interdomain interface in full-length FimH.
We then determined the co-crystal structure of FimHK12 DsF
with HM (FimHK12 DsF HM) at 3.0 Å resolution with four
molecules in the asymmetric unit. Three FimHK12 DsF HM
molecules closely resembled the Abound state (r.m.s.d. of 0.6 Å to
FimHF18 DsG HM) with a preserved interdomain interface. In
the fourth molecule, however, the FimHL and FimHP domains
were separated and they adopted a drastically different relative
orientation with an angle between the domains of B45 instead
of B150 in the other three molecules (Fig. 2a). FimHP is
virtually identical in all four FimH molecules in the crystal
(r.m.s.d. 0.4 Å). In contrast, the FimHL domain differs
significantly between the fourth, domain-separated and the three
full-length FimH molecules in the crystal. It shows closest
similarity to the isolated FimHL HM (r.m.s.d. 0.45Å); in
particular, all interdomain loops adopt identical conformations,
which are incompatible with domain association (Figs 2c and 3).
Remarkably, in the bent fourth molecule, no interactions between
FimHL and FimHP other than the direct covalent linkage are
detected, equivalent to a breakdown of the total 500Å2
interdomain interface of the Abound state (Fig. 3). This molecule
thus represents a third state, the domain-Separated, ligand-
bound state of FimH, Sbound. The complete absence of non-
covalent interdomain interactions indicates that the Sbound state
does not possess a defined relative domain orientation in solution,
and that the observed, kinked conformation has been selected
only by crystal packing.
To analyse the transition trajectory of the Abound to the Sbound
state, we removed the FimHP domain after equilibration from the
Abound state in silico for a 180-ns molecular dynamics simulation
(Supplementary Fig. 3e,f). In contrast to the transition between
the Abound and Afree states on ligand removal, a sharp transition
to the conformation of FimHL in the Sbound state was not
observed. The conformation only slowly moved towards Sbound;
however, the FimHL loops that had formed in the former
interdomain interaction kept fluctuating throughout the
simulation, indicating lower cooperativity and potentially a
higher activation energy for the Abound-Sbound compared with
the Abound-Afree transition.
A comparison of the structural dynamics in the Abound and
Sbound states clearly reveals differences in the FimHL–FimHP
interface region. The root-mean-square fluctuations of atom
positions (r.m.s.f.) increase in the swing and insertion loop
from a background level of B0.7 Å in Abound to 1.5 and 2Å in
Sbound, respectively. Surprisingly, despite the virtually identical
conformations of the entire ligand-binding site depicted by X-ray
crystallography (Fig. 2b), the clamp loop, which exhibits the most
significant conformational changes between the open and closed
Table 1 | Data collection and refinement statistics
FimHF18 .DsG FimHK12 .DsG FimHK12 .DsG .HM FimHF18 .DsG .HM FimHK12 .DsF .HM FimHL
F18 .HM FimHL
K12 .HM
Data collection
Space group C 1 2 1 C 1 2 1 P 1 P 21 3 I 21 21 21 C 2 2 21 P 21 21 21
Cell dimensions
a, b, c (Å) 99.3, 35.5, 72.8 99.5, 35.6, 72.9 56.5, 77.6, 78.1 128.4, 128.4, 128.4 94.5, 147.1, 250.8 140.1, 176.1, 28.3 63.0 68.4 95.9
a, b, g () 90, 105, 90 90, 105, 90 101.5, 111.1, 96.3 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (Å) 70–1.14 (1.21–1.14) 48–1.14 (1.2–1.14) 52–2.54 (2.63–2.54) 128–2.4 (2.5–2.4) 48.1–3.0 (3.19–3.0) 54–1.42 (1.47–1.42) 52–1.7 (1.76–1.7)
Rmerge 0.039 (0.760) 0.038 (0.691) 0.161 (0.859) 0.207 (2.424) 0.427 (1.741) 0.121 (1.242) 0.129 (1.278)
CC1/2 100.0 (68.0) 100.0 (84.2) 99.2 (82.2) 99.8 (56.3) 95.8 (46.7) 100.0 (71.0) 99.9 (57.7)
I/sI 16.6 (1.6) 17.8 (2.8) 8.79 (2.0) 18.3 (1.6) 14.4 (1.2) 17.9 (2.0) 15.1 (1.7)
Completeness
(%)
97.6 (83.5) 94.7.0 (81.5) 90.7 (89.4) 99.9 (99.9) 99.9 (98.7) 98.9 (94.4) 96.9 (79.3)
Redundancy 3.1 (2.5) 3.2 (2.5) 3.4 (3.5) 20.4 (20.0) 6.6 (4.1) 16.9 (13.4) 11.5 (6.3)
Refinement
Resolution (Å) 70.1–1.14 47.9–1.14 52.6–2.54 74.1–2.4 48.13–3.0 54–1.42 52.6–1.7
No. reflections 273774 (87283) 277806 (85217) 122641 (11994) 567915 (28396) 172553 (35275) 83287 (6222) 518524 (23173)
Rwork/Rfree 0.165/0.185 0.153/0.175 0.227/0.276 0.155/0.179 0.220/0.251 0.149/0.175 0.171/0.196
No. atoms 3102 3086 8855 2866 8751 3099 3232
Protein 2590 2590 8690 2558 8652 2427 2407
Ligand/ion — — — 19 86 57 38
Water 512 496 165 284 13 596 471
B-factors
Protein 13.8 13.3 43.7 33.5 53.2 13.2 21.3
Ligand/ion — — 39.7 21.3 32.3 23.0 20.7
Water 26.2 23.6 22.4 39.1 25.9 28.2 40.6
R.m.s deviations
Bond length
(Å)
0.009 0.01 0.019 0.013 0.004 0.015 0.004
Bond angles
()
1.29 1.45 1.78 1.38 0.82 1.62 1.02
*Values in parenthesis are for the highest resolution shell.
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conformations, exhibits strongly reduced fluctuations in Sbound,
with r.m.s.f. decreasing by up to 1.5 Å (Supplementary Fig. 3g,h).
This change in clamp loop dynamics provides a mechanistic link
between domain association and ligand-binding in full-length
FimH.
Domain association alters FimH–ligand-binding kinetics.
To analyse the ligand-binding properties of FimH DsG, we
exploited the increase in intrinsic tryptophan fluorescence in the
FimH DsG complexes of B10% on HM binding (Fig. 4a). This
difference was used to measure the dissociation constant of HM
binding by equilibrium titration (Fig. 4b) and the rates of HM
binding and dissociation by stopped-flow fluorescence kinetics
(Fig. 4c,d). The FimH DsG constructs showed uniform binding
and dissociation kinetics, consistent with the view that domain-
separated states of FimH are not significantly populated in
the absence of shear force. The results revealed equilibrium
dissociation constants (Kd) of 3.6 and 9.9mM for FimHK12 DsG
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Figure 3 | The interdomain region in the Sbound state. Close-up of the
interdomain region of FimHK12 DsF HM in the Abound form (left) and
FimHK12 DsF HM in the Sbound state (right). A cartoon representation for
each crystal structure, similar to Fig. 1a, is given. Key residues in the
interface are shown as sticks. FimHP, FimHL and DsF are coloured in yellow,
red and green, respectively.
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and FimHF18 DsG, respectively (Table 2). HM binding to
FimH DsG is extremely dynamic and was characterized by fast
association rates (kon) of 5.0 106 and 4.9 106M 1s 1,
respectively, and rapid dissociation reactions (Supplementary
Fig. 4). The rates of HM dissociation (koff) of 22 and 58 s 1 for
FimHK12 DsG and FimHF18 DsG translate into dissociation
half-lives of only 32 and 12ms, respectively.
In contrast to full-length FimH, isolated FimHLK12 showed no
change in tryptophan fluorescence on HM binding. We therefore
determined the HM affinity of isolated FimHL indirectly
by a competition experiment based on a newly designed
fluorescent ligand, the fluorescein-labelled a-D-mannoside
GN-FP-4 (Supplementary Fig. 5a–e and Supplementary Note 1).
Displacement of GN-FP-4 from FimHL by increasing HM
concentrations under equilibrium conditions showed that both
FimHLK12 and FimHLF18 bind HM with 3,300-fold higher affinity
compared with the respective FimH DsG complexes (Kd values
1.1 and 3.0 nM, respectively; Fig. 5a and Table 2). In an inverse
competition experiment (Supplementary Fig. 5f–j), in which HM
in preformed FimHL HM complexes was displaced by GN-FP-4,
off-rates of 2.0 10 4 and 3.5 10 4 s 1 were determined for
FimHLK12 and FimHLF18, respectively, corresponding to dissocia-
tion half-lives of 58 and 33min (Table 2). On the basis of these
measured off-rates and equilibrium dissociation constants, kon
rates of 1.8 105 and 1.2 105M 1 s 1 were calculated for
FimHLK12 and FimHLF18, respectively. The on-rates for the isolated
FimHL domains are thus 30-fold lower than those of the
corresponding full-length FimH DsG complexes.
Together, these results demonstrate that the 3,300-fold higher
affinity of the isolated FimHL compared with full-length FimH
results from a more than 100,000-fold lower ligand dissociation
rate in isolated FimHL, combined with a ligand-binding rate
reduced by only 30-fold (Table 3). The 3,300-fold higher affinity
for HM of FimHL relative to FimH DsG translates into a free
energy of 20 kJmol 1 for the interaction between FimHL and
FimHP in full-length FimH. This corresponds very well with
the mechanical work required for domain separation, as a
displacement of FimHL from FimHP by 11Å for complete
domain separation (Fig. 2a)17, and a force of 40 pN required to
populate the domain-separated state of FimH31 yields a value of
26.5 kJmol 1.
Domain association in FimH promotes bacterial motility.
Uropathogenic E. coli require firm adhesion to the urinary
epithelium under flow conditions to escape clearance by urine
excretion. On the other hand, bacterial adhesion must be weak
enough in the absence of external shear to allow flagellar motility
as a prerequisite for the invasion of new tissue areas32,33. While
the role of FimH catch-bond binding for adhesion under flow
conditions had clearly been demonstrated12,29,34, the relevance of
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Figure 4 | Kinetics of HM binding and release by full-length FimH. (a) Fluorescence spectra (excitation at 280 nm) of FimHL
F18 (2mM; red lines) and
FimHF18 DsG (2mM; black lines) in the absence (solid lines) or presence of 200mM HM (dotted lines). (b) Equilibrium titration of FimHF18 DsG (2mM)
with HM, recorded via the fluorescence increase at 320 nm. The total concentration of HM is plotted against the recorded fluorescence signal. Data were
fitted (solid line) according to equation (2) (cf. experimental section) and yielded a Kd value of 9.9±1.5mM. (c) Stopped-flow fluorescence kinetics of HM
binding to FimHF18 DsG (1.0 mM), recorded via the fluorescence change above 320 nm. The HM concentration was varied between 0 and 50mM. Five
representative traces are shown (HM concentrations are given in mM). The fluorescence traces were globally fitted according to a second-order binding
and first-order dissociation reaction (solid lines; Table 2). (d) Amplitudes of the reactions monitored in c, plotted against the total HM concentration. Data
were fitted (solid line) according to equation (2), yielding a Kd value of 12±1mM.
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rapid ligand dissociation under static conditions for flagellar
motility remained unclear because of the complex interplay of
flagellar swimming and the avidity of multivalent surface
interactions by hundreds of E. coli pili. Here we employed
single-cell tracking of piliated E. coli cells moving on surfaces
coated with mono-mannosylated bovine serum albumin
(1M-BSA), an established model system for analysing FimH-
based adhesion12,29, for a classification of cell motility into two
states, attached or mobile (for details see Methods and
Supplementary Fig. 6). To study the influence of FimH
interdomain interactions, we compared isogenic E. coli strains
producing either wild-type FimHF18 or the FimHF18-variant
Ala188Asp, which is characterized by a destabilized interaction
between FimHP and FimHL (ref. 26) and serves here to mimic the
Sbound state in the absence of shear force35. The overall fraction of
adherent FimHF18-piliated bacteria on 1M-BSA-coated surfaces
was identical to background levels on non-adhesive BSA-coated
surfaces at 10–12% of tracked bacteria (Fig. 6a). In contrast,
FimHF18–Ala188Asp-piliated bacteria showed an increased
fraction of adherent cells of 24% already at the beginning of
cell tracking after a 1-min dead time, which further increased
during the 5-min observation period to 48% (Fig. 6a and
Supplementary Movies 1 and 2).
Cell tracking permitted quantitative analysis of the transition
of individual cells between a mobile and an attached state
(Supplementary Fig. 7). On non-adhesive control surfaces coated
only with BSA, less than 2% of all FimHF18- or FimHF18–
Ala188Asp bacteria showed shifts between the two states of
motion (Fig. 6b and Supplementary Fig. 7c). However, on
adhesive 1M-BSA surfaces, 13.9% of all FimHF18 tracks (green in
Fig. 6b) exhibited a single transient attachment event with a mean
duration of 6.9 s (Supplementary Fig. 7d). For FimHF18–
Ala188Asp-piliated bacteria, only 7.2% of the cells showed
attachment/detachment, but with fivefold longer adhesion
(35.2 s; Supplementary Fig. 7d). Remarkably, the fraction of cells
that permanently stayed attached after adhesion to 1M-BSA until
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Figure 5 | HM binding and release by the isolated FimH lectin domain FimHL. Analysis of FimHL HM interactions based on competition between
HM and the synthetic fluorescent GN-FP-4 ligand. (a) HM binding to FimHL analysed by displacement of GN-FP-4 from FimHL variants as indicated.
An equimolar mixture of FimHL and GN-FP-4 (1 mM each) was incubated with different HM concentrations (10 nM–3.2mM) for 418 h. GN-FP-4
displacement is monitored by a decrease in fluorescence polarization at 528±20nm (excitation at 485 nm). Data were fitted (solid lines) according to a
mechanism in which two ligands compete for the same binding site, with fixed Kd values for GN-FP-4 binding (cf. Table 2). (b) Kinetics of HM dissociation
from FimHL. A solution with equimolar concentrations of FimHL and HM (3 mM each, guaranteeing 495% occupancy with HM) was mixed with excess
GN-FP-4 (10mM), and the decrease in GN-FP-4 fluorescence at 520nm as a consequence of HM dissociation and GN-FP-4 binding was recorded
(Supplementary Fig. 5f–j). The obtained first-order kinetics are independent of the GN-FP-4 concentration and thus directly monitor HM dissociation.
Table 2 | Kinetics and thermodynamics of HM binding to FimHL or FimH DsG at pH 7.4 and 25 C.
Protein kon (M
 1 s 1) koff (s 1) koff/kon (M)(a) Kd (amplitude analysis; M)(b) Kd (equilibrium titration; M)(c)
FimHL
K12 1.8±0.6 105(d) 2.0±0.4 104 n.a. n.a. 1.1±0.1 109(e)
FimHK12 DsG 5.0±0.1 106 2.2±0.1 101 4.3±0.1 106 4.2±0.3 10 6 3.6±0.3 106
FimHL
F18 1.2±0.4 105(d) 3.5±0.8 104 n.a. n.a. 3.0±0.2 10 9(e)
FimHF18 DsG 4.9±0.1 106 5.8±0.1 101 1.2±0.04 10 5 1.2±0.1 10 5 9.9±1.5 10 6
HM, n-heptyl a-D-mannoside.
The rate constants kon and koff were determined from experiments as shown in Figs 4 and 5. The KD values for the complex formation between HM constructs and the different FimH constructs were
determined (a) from the ratio of rate constants (koff/kon), (b) from the analysis of the amplitudes as in Fig. 4d and (c) from equilibrium titration as in Fig. 4b. (d) kon values were calculated with koff and Kd.
(e) Values of Kd were obtained from competition equilibria with the fluorescent mannoside GN-FP-4 (Fig. 5a) and the following Kd values of GN-FP-4 binding determined in Supplementary Fig. 5: FimHL
K12:
Kd¼ 7.0±0.1 10 11M; FimHLF18: Kd¼ 1.8±0.2 10 10M.
Table 3 | Comparison of HM binding by variants of FimHL
versus FimH DsG.
FimH
variant
kon (FimH DsG)/
kon (FimHL)
koff (FimH DsG)/
koff (FimHL)
Kd (FimH DsG)/
Kd (FimHL)
K12 28 110,000 3,300
F18 41 170,000 3,300
HM, n-heptyl a-D-mannoside.
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the end of the observation period was much larger for FimHF18–
Ala188Asp (11.5%) than for FimHF18 (0.6%; red in Fig. 6b).
Those permanently attached cells escape kinetic analysis; thus, the
true average attachment time for FimHF18–Ala188Asp must be
considerably larger than 35.2 s. Permanent attachment is also the
main cause of the increased fraction of attached cells for
FimHF18–Ala188Asp-piliated bacteria (Fig. 6a).
Altogether, cell-tracking analysis revealed that enforced
domain separation in the FimHF18–Ala188Asp variant resulted
in reduced detachment rates and a larger proportion of
permanently attached cells. These results directly demonstrate,
at the cellular level, the importance of fast, spontaneous ligand
dissociation catalysed by interdomain allostery in FimH–ligand
complexes for bacterial motility in the absence of tensile
mechanical forces.
Discussion
The characterization of full-length FimH had so far been
restricted to the analysis of the adhesive properties of piliated
E. coli cells and binding studies with the purified type 1 pilus tip
fibrillum. With the FimH DsG complex, we have now estab-
lished a model system for quantitative studies of the interaction of
FimH with carbohydrate ligands. Soluble FimH DsG efficiently
mimicks FimH in the context of the assembled tip fibrillum, is
readily available in milligram quantities and permits the
determination of ligand-binding and release kinetics in solution.
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Using FimH DsG, we obtained high-resolution snapshots of
three functionally relevant states of FimH (Fig. 7). In the absence
of ligands, FimH adopts the Afree state with associated FimHL and
FimHP and an open conformation of the ligand-binding site,
which is responsible for the 30-fold faster ligand-binding of
full-length FimH as compared with the isolated FimHL domain.
Ligand-binding in the absence of shear force induces the Abound
state with a closed binding site. In contrast to earlier
hypotheses17, the transition from Afree to Abound is restricted to
the ligand-binding site, while all interactions between FimHL and
FimHP observed in the Afree state remain preserved in Abound.
The Afree-Abound transition most likely follows an induced fit
mechanism, in which the formation of an encounter complex
between FimH DsG and HM is rate-limiting and followed by a
fast, unimolecular rearrangement to the Abound state, in
agreement with the observation that binding of the model
ligand HM remained rate-limiting for the formation of Abound
even at the highest HM concentrations used. Stopped-flow-
binding kinetics indicate that the lifetime of the proposed
encounter complex before Abound formation is below 1ms
(Fig. 4c). Under tensile mechanical force applied to the FimH–
ligand complex, mimicked here by the destabilized variant
FimH DsF and crystal packing forces, the domain-separated
state of FimH, Sbound, is formed. In the Sbound state, FimHL and
FimHP no longer interact specifically and are only connected via
the linker segment comprising FimH residues 154–160. In this
Sbound state, FimHL adopts a conformation closely resembling
isolated FimHL with bound ligand.
Notably, ligand dissociation from FimH DsG is 100,000-fold
faster than that from the isolated FimHL domain. This is striking
because the respective crystal structures revealed indistinguish-
able ligand interactions and binding-site conformations in the
FimH DsG HM and FimHL HM complexes (Fig. 2b). MD
simulations identified a considerable increase in the conforma-
tional dynamics of the FimHL–ligand-enclosing clamp loop in the
Abound state as the most likely cause of the dramatic increase in
koff in the FimH DsG HM complex. The altered dynamics in
FimHL in the Abound state are the result of the presence of FimHP,
which can be described as a negative allosteric regulator36–38.
The allosteric communication from the FimHP–FimHL interface
to the ligand-binding site reaches over 40Å, and is mediated via
changes in protein dynamics rather than in static structure,
in line with a general model of dynamic allostery39,40. Our
data demonstrate that the interdomain interactions in FimH
(i) maintain the open conformation of the binding pocket and
guarantee rapid ligand-binding and (ii) intramolecularly catalyse
ligand dissociation by more than 100,000-fold. Rapid ligand-binding
and short lifetimes of the FimH ligand complex allow for rapid
dissociation of individual pili from their ligands in the absence of
shear force. Our biophysical data demonstrate that this mechanism
is conserved between the K12 and the F18 E. coli strains.
Different mechanistic models, such as the two-pathway41, the
deformation42 and the sliding re-binding model43, have been
developed to describe catch-bond interactions, often based on
powerful single-molecule atomic force measurements. These
models included the principle of allosteric control of ligand-
binding affinity26,31, which was clearly fully confirmed in our
present study. However, these conceptual models did not
reveal the underlying atomic-scale mechanisms in different
catch-bond systems. For most catch-bond systems, including
the cadherin–catenin binding to actin filaments3,44, integrin
epithelial cell adhesion45,46 and TCR–MHC interactions6,7,47,
structural information is, if at all, available only for one state
or from computer simulations. One exception is the selectins,
which employ catch-bond binding for leukocyte recruitment.
Selectins are multidomain cell surface receptors, which consist
of a lectin domain for complex carbohydrate binding, linked
via an epidermal growth factor (EGF)-like domain to a
variable number of short consensus repeat domains and a
transmembrane-anchoring helix. Selectins exist in two
conformations, a bent and an extended one, which differ in the
angle between their lectin and EGF-like domain. Ligand-binding
and conformational changes in the ligand-binding site are directly
linked via a complex allosteric coupling mechanism to the
adoption of the extended conformation48,49. Tensile mechanical
force under flow conditions acts along the axis of the ligand-
binding site and the Lec-EGF interface resulting in a stabilization
of the extended conformation and thus increased ligand complex
lifetimes2,49. Moreover, in FimH, catch-bond behaviour is
mediated by the interplay of a lectin and an anchoring domain
that does not interact with the ligand. Ligand-binding by FimH
in the absence of shear force results in a closing of the
ligand-binding site, but, in contrast to selectins, is not directly
linked to altered interdomain interactions. Here mechanical force
promotes domain separation and completely releases FimHL
from FimHP, which acts as an activator of ligand release via
dynamic allostery. Remarkably, selectins and the fimbrial adhesin
FimH thus employ entirely different mechanisms for establishing
catch-bond behaviour by crosstalk between a lectin and an
anchoring domain that provides tethering to a shaft. In both
systems, the selectins and fimbrial adhesion, the shaft structures
linking the terminal lectin/coupling domains to the cell surface,
may contribute to the overall catch-bond behaviour, either via
directly influencing coupling domain behaviour or via their
general elastic properties50,51.
The cell-tracking experiments indicate the importance of rapid
ligand release from the high-mannose-type glycoprotein receptor
uroplakin 1a in the lower urinary tract52 for flagellar motility of
piliated bacteria, and hence their ability to colonize new tissue
areas under certain conditions during infection12,29,53. This
provides a plausible explanation for the fact that low-affinity
FimH variants were preserved in numerous uropathogenic E. coli
strains. Binding of terminal mannoses with low affinity in the
absence of shear force may also play a role in preventing the
clearance of uropathogenic E. coli from the urinary tract by
competitive binding to the Tamm–Horsfall protein in the urine54.
In turn, populating the Sbound state with an extremely low
dissociation rate ensures tight bacterial adhesion under the
mechanical forces of urine excretion. FimH is a promising target
for anti-adhesive therapy of UTI because FimH antagonists, in
contrast to antibiotics, are not exerting selection pressure towards
resistance formation18,55,56. Previous ligand-binding studies on
the isolated FimHL domain mimic the domain-separated Sbound
state of FimH. This state is characterized by extremely low
off-rates and is promoted in vivo only after ligand-binding and
the onset of flow conditions. Our kinetic data on ligand
dissociation from full-length FimH demonstrate that rapid,
competitive displacement of FimH from its carbohydrate
ligands by FimH antagonists is well possible in the absence of
shear force. Thus, full-length FimH (for example, in the form of
the FimH DsG complex established in this study) instead of the
isolated FimHL domain is the relevant target for the development
of anti-adhesive drugs. Importantly, the concept of the
FimH DsG model system can now be expanded to other
related adhesive pilus adhesins. In combination with the novel
fluorescent GN-FP-4 ligand, this model system paves the way for
efficient screening for anti-adhesive drug candidates.
Methods
Materials. The synthetic DsG (sequence: ADVTITVNGKVVAKR) and DsF
peptide (sequence: ADSTITIRGYVRDNG; 495% purity) were purchased from
JPT (Germany). Guanidinium chloride (‘AA-Grade’ for spectroscopy) was
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obtained from NIGU Chemie (Germany). Standard chemical of highest purity
available was obtained Sigma, Merck or AppliChem. If not mentioned otherwise,
chromatography media for protein purification were purchased from GE
Healthcare (UK). Oligonucleotides were from Microsynth (Switzerland).
Construction of expression plasmids. Expression plasmids for the periplasmic
production of the E. coli F18 FimH lectin domain (FimHLF18) and for the
periplasmic co-expression of full-length FimHF18 with FimC were based on the
expression plasmids pfimHL and pfimH-fimC-ATG, respectively, for the analogous
proteins from E. coli K12 (ref. 27). Six silent mutations replacing rare codons were
introduced into the E. coli F18 fimH gene (fimHF18) contained in the plasmid
pGB2-24 (ref. 57) with the QuikChange mutagenesis kit (Agilent Technologies,
Switzerland) to improve periplasmic expression. The coding sequence of the
modified fimHF18 gene was amplified by PCR using the primers 50-GATCCTCTA
GAGGAGGGATGATTGTAATGAAACGAG-30 and 50-TTTCAAGCTTATTGA
TAAACAAAAGTCACG-30 and cloned into pfimH-fimC-ATG27 via the XbaI and
HindIII sites (thereby replacing the fimHK12 gene) and yielded pfimHF18–fimC–
ATG. The gene encoding FimHLF18 was amplified with the primers 50-GATCCTCT
AGAGGAGGGATGATTGTAATGAAACGAG-30 and 50-CAGCCAAGCTTAG
CCAGTAGGCACCACCAC-30 and ligated via the XbaI and HindIII sites into
ptrc99a-f1-stopp27. Protein production in the resulting plasmid pfimHLF18 is
under control of the trc–promotor/lac operator.
Protein production and purification. For purification of the complexes
FimC  FimHK12 and FimC  FimHF18, E. coli HM125 harbouring the correspond-
ing co-expression plasmid was grown at 30 C in 2YT medium containing
ampicillin (100 mgml 1). At an OD600 of 1.5, isopropyl-b-D-thiogalactoside
(IPTG) was added to a final concentration of 1mM. The cells were further grown
for 12 18 h, harvested by centrifugation, suspended in cold 50mM Tris-HCl pH
7.5, 150mM NaCl, 5mM EDTA, 1mgml 1 polymyxin B sulfate (18ml l 1
of culture) and stirred at 4 C for 1.5 h. After centrifugation, the supernatant
(periplasmic extract) was dialysed against 20mM Tris-HCl pH 8.0 and applied to a
QA52 (Whatman, Maidstone, UK) column equilibrated with the same buffer. The
flow-through containing the respective FimC  FimH complex was dialysed against
20mM MOPS–NaOH pH 7.0, loaded onto a Resource S column equilibrated with
the same buffer and the complexes were eluted with a linear NaCl gradient
(0 400mM). Fractions containing FimC  FimH were pooled and loaded onto a
Superdex 75 (HiLoad 26/60) column equilibrated with 20mM NaH2PO4–NaOH
pH 7.4, 50mM NaCl. Fractions containing the pure complex were pooled and
stored at 4 C until further use. Typically, 3 5mg of the purified complex were
obtained per litre of bacterial culture.
For expression of the isolated E. coli FimHLK12 and FimHLF18, E. coli HM125
transformed with the respective expression plasmid was grown at 30 C in M9
medium containing ampicillin (100 mgml 1) to an OD600 of 1.0, and expression
was induced with 1 mM IPTG. After further growth for 12 h, cells were subjected to
periplasmic extraction (see above). The extracts were mixed with 0.11 volumes of
1M acetic acid–NaOH pH 4.5, dialysed against 10mM acetic acid–NaOH pH 4.5
and then loaded onto a SP-Sepharose column equilibrated with the same buffer.
The flow-through was collected and its pH was adjusted to 8.0 by addition of 1M
Tris-HCl pH 8.2. This solution was then applied to a Q-Sepharose column
equilibrated with 20mM Tris-HCl pH 8.0. The flow-through containing FimHL
was loaded onto a Resource S column dialysed against 20mM formic acid–NaOH
pH 4.0. The protein was eluted with a linear NaCl gradient (0 1M). Fractions
containing pure FimHL were pooled, dialysed against water and stored at  20 C.
The identity of the purified proteins was confirmed by electrospray ionization
(ESI)–mass spectrometry (FimHLF18: calculated: 16,934.9 Da; measured:
16,935.0 Da; FimHLK12: calculated: 16,963.0 Da; measured: 16,962.8 Da). About
11mg of the pure FimHL was obtained per litre of bacterial culture.
Production of FimH .DsG and FimHK12 .DsF complexes. The respective
FimC  FimH complex (40 mM) was incubated with a threefold molar excess of the
DsG peptide and incubated in 20mM NaH2PO4–NaOH, pH 7.0, 50mM NaCl for
48 h at 37 C. The reaction mixture containing isolated FimC, the FimH DsG
complex and excess DsG was dialysed against 20mM acetic acid–NaOH pH 4.5
and loaded onto a Resource S (6ml) column equilibrated with the same buffer.
The FimH DsG complex was eluted with a linear NaCl gradient (0 400mM).
Fractions containing the pure complex were pooled, dialysed against water and
stored at 4 C. The FimH DsG partially dissociated during ESI–mass spectrometry
analysis, so that masses of the intact complexes and free FimH were obtained:
FimHK12 DsG: calculated mass: 30,635.3 Da; measured mass: 30,636.0 Da;
FimHF18 DsG: calculated mass: 30,607.3 Da; measured mass: 30,607.0 Da;
FimHK12: calculated mass: 29,064.5 Da; measured mass: 29,064.0 Da; FimHF18:
calculated mass: 29,036.4 Da; measured mass: 29,036.0 Da. The overall yields of the
purified FimH DsG complexes relative to the initial amount of FimC  FimH were
in the range of 50–55%. The FimHK12 DsF complex was generated and purified
as described for the FimH DsG complexes (FimHK12 DsF: calculated mass:
30,702.2 Da; measured mass: 30,702.5 Da). The FimH DsF complex was prepared
from the FimC  FimH complex after mixing with DsF exactly according to the
protocol described above for FimH DsG and obtained in similar yields. Despite
the non-natural interaction between FimHP and DsF, the FimHK12 DsF complex
was formed four times faster than the FimHK12 DsG complex at pH 7.0 and 37 C,
with a rate constant of 2.2±0.5M 1 s 1. The FimH DsF complex was stable
against dissociation and unspecific aggregation.
Determination of protein concentrations. Protein concentrations were measured
via the specific absorbance at 280 nm, using the following extinction coefficients
(FimHK12 and FimHF18 have identical extinction coefficients): FimC  FimH
(59,090M 1 cm 1), FimHL (24,670M 1 cm 1), FimH DsG (35,090M 1
cm 1) and FimH DsF (36,580M 1 cm 1). The concentrations of DsG and DsF
were determined via their absorbance at 205 nm (42,650 and 49,700M 1 cm 1,
respectively).
Synthesis of the fluorescent-labelled FimH ligand GN-FP-4. To a stirred
solution of mannoside 1 (25mg, 0.061mmol)55 in dry dimethylformamide (DMF;
1ml), N-hydroxysuccinimide (21mg, 0.183mmol) was added, followed by
N,N0-dicyclohexylcarbodiimide (9.2mg, 0.073mmol). The mixture was stirred at
room temperature for 2 h, then N-Boc-ethylendiamine (10.7mg, 0.067mmol) was
added and the reaction was stirred for an additional 10 h. After cooling to 0 C,
the reaction mixture was diluted with water and concentrated. Chromatography
on silica gel (CH2Cl2/MeOH) yielded 23mg (0.042mmol, 68%) of tert-butyl
(30-chloro-40-(a-D-mannopyranosyloxy)-biphenyl-4-yl-carboxamido)ethyl)carbamate.
This product was dissolved in CH2Cl2 (3ml) and trifluoroacetic acid (TFA, 1ml)
was added. The solid dissolved during addition of TFA. After 10min at room
temperature the reaction was complete. The mixture was evaporated and excess
TFA was removed in high vacuum. The intermediate N-(2-aminoethyl)-30-
chloro-40-(a-D-mannopyranosyloxy)-biphenyl-4-carboxamide TFA salt (23mg,
0.042mmol, quant.) was used without purification in the next step. After
dissolution in dry DMF (0.5ml), triethylamine (12.8mg, 0.127mmol) was added.
The mixture was cooled to 0 C, then fluorescein isocyanate (14.8mg, 0.038mmol)
was added and the mixture was stirred for 3 h in the dark. After the addition of
water, DMF was removed azeotropically, the residue dissolved in MeOH/10%
acetic acid and evaporated. Chromatography on silica gel (CH2Cl2/MeOH) yielded
compound 2, contaminated with triethylammonium acetate. Therefore, after
dissolution in MeOH, 0.5N HCl in MeOH was added, the mixture evaporated
and chromatographed on silica gel to yield pure compound GN-FP-4 ((30-Chloro-
N-(2-(3-(30 ,60-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,90-xanthen]-5-yl)-
thioureido)ethyl)-40-(a-D-mannopyranosyloxy)-biphenyl-4-carboxamide)58
(15mg, 47%). [a]D20þ 12.1 (c 0.3, MeOH); 1H NMR (500MHz, CD3OD): d¼ 8.12
(s, 1H), 7.92 (d, J¼ 8.3Hz, 2H, Ar–H), 7.70 (dd, J¼ 5.0, 13.1Hz, 2H, Ar–H), 7.64
(d, J¼ 8.3Hz, 2H, Ar–H), 7.54 (dd, J¼ 2.2, 8.6Hz, 1H, Ar–H), 7.46 (d, J¼ 8.7Hz,
1H, Ar–H), 7.09 (d, J¼ 8.2Hz, 1H, Ar–H), 6.74 (s, 2H), 6.69 (d, J¼ 1.4Hz, 2H,
Ar–H), 6.55 (d, J¼ 8.4Hz, 2H, Ar–H), 5.63 (d, J¼ 1.3Hz, H-1), 4.15 (dd, J¼ 1.8,
3.1 Hz, H-2), 4.03 (dd, J¼ 3.4, 9.5Hz, H-3), 3.94 (s, 2H, CH2), 3.86-3.64 (m, 6H,
H-4, H-5, H-6, CH2); 13C NMR (126MHz, CD3OD): d¼ 153.21, 143.84, 136.41,
129.66, 129.18, 127.76, 127.70, 125.37, 118.64, 103.62 (Ar-C), 100.75 (C-1), 76.00
(C-5), 72.41 (C-3), 71.86 (C-2), 68.24 (C-4), 62.69 (C-6), 40.76 (CH2); ESI–MS:
m/z: Calculated for C42H37ClN3O12S [MþH]þ : 842.2, found: 842.2.
Fluorescence spectroscopy. Fluorescence emission spectra of FimH variants were
recorded between 300 and 450 nm (excitation at 280 nm) at 25 C in 1.0 0.4-cm
quartz cuvettes on a QM 7/2003 spectrofluorimeter (PTI, USA) equipped with a
magnetic stirrer. Protein concentrations were 1 2 mM in 20mM MOPS–NaOH
pH 7.4. Fluorescence spectra of GN-FP-4 (e495 nm¼ 54,900M 1 cm 1) were
recorded between 500 and 650 nm (excitation at 497 nm) in the same buffer.
Kinetics of HM binding to FimH .DsG. The rate constants of binding (kon) and
dissociation (koff) for the complex between FimH DsG and HM were measured at
25 C in 20mMMOPS–NaOH pH 7.4 in a SX20 stopped-flow instrument (Applied
Photophysics, UK). A constant FimH DsG concentration of 1 or 2 mM was used.
FimH DsG was mixed with different concentrations of HM (2 100 mM), and
binding was monitored by the increase in fluorescence above 320 nm (excitation at
280 nm). The fluorescence traces were globally fitted with Dynafit59 according to a
second-order binding and first-order dissociation reaction. As an additional
control, the fluorescence amplitudes of the individual reactions were plotted against
the total HM concentration and fitted according to equation (2). The deduced
dissociation constants reproduced the Kd values obtained with equilibrium titration
within experimental error.
Equilibrium titration of FimH .DsG with HM. The binding equilibrium between
FimH DsG and HM was followed at 25 C in 20mM MOPS–NaOH pH 7.4 on a
QM 7/2003 spectrofluorometer (PTI) by the increase in fluorescence at 320 nm on
HM binding (excitation at 280 nm). Measurements were performed with a stirred
1 0.4-cm quartz cuvette. The concentration of FimH DsG was kept constant at
2 mM and the concentration of HM was varied between 0 and 200mM. The samples
were equilibrated overnight, and their fluorescence intensities were recorded for
30 s and averaged. The fluorescence intensities were plotted against total HM
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concentration and fitted according to equation (2)
F ¼ F1  F0ð Þ 
P½ 0 þ L½ 0 þKd 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð P½ 0 þ L½ 0 þKdÞ2  4  P½ 0 L½ 0
q
2  P½ 0
þ F0 ð2Þ
where F is the monitored fluorescence signal, F0 is the fluorescence signal in
absence of ligand, FN is the fluorescence signal at full saturation with ligand, Kd is
the dissociation constant, [P]0 is the total concentration of FimH DsG and [L]0 is
the total concentration of HM.
Equilibrium titration of FimHL with GN-FP-4. The binding equilibrium between
FimHL and GN-FP-4 at 25 C in 20mM MOPS–NaOH pH 7.4, supplemented with
0.001% Tween 20 to prevent unspecific adsorption effects at nanomolar con-
centrations, was recorded by the decrease in GN-FP-4 fluorescence at 520 nm
(excitation at 497 nm). Measurements were performed with a stirred 1 0.4-cm
quartz cuvette. The concentration of GN-FP-4 was kept constant at 1.0 or 2.0 nM
and the concentration of FimHL was varied between 0 and 10 nM. The samples
were equilibrated overnight, and their fluorescence intensities at 520 nm were
recorded for 30 s and averaged. The experimental data were fitted according to
equation (2).
Displacement of HM from the FimHL by GN-FP-4. The rate constant of
dissociation (koff) for HM from FimHL at 25 C in 20mM MOPS–NaOH pH 7.4
was measured indirectly by binding of excess GN-FP-4 to FimHL after dissociation
of HM, recorded with the decrease in GN-FP-4 fluorescence at 520 nm (excitation
at 497 nm). A mixture of FimHL and HM (3 mM each), pre-incubated for at least
18 h, was mixed with different amounts of excess GN-FP-4 (final concentrations:
10 40mM), and GN-FP-4 fluorescence was recorded every 10min for 10 s,
averaged and the data fitted according to first-order kinetics. The obtained rate
constants were independent of GN-FP-4 concentration and thus identical to the
dissociation rate of HM from FimHL.
Determination of the FimHL .HM dissociation constant. The affinity of
FimHL for HM at 25 C in 20mM MOPS–NaOH pH 7.4 was determined by the
competition between HM and GN-FP-4 for binding to FimHL. A mixture of FimHL
and GN-FP-4 (1 mM each) was incubated with different concentrations of HM
(10–3.2mM) and incubated for at least 18 h. The displacement of GN-FP-4 by HM
was recorded on by the decrease in the fluorescence polarization at 528±20 nm
(excitation at 485±20 nm) on a microplate reader (Biotek, USA), using flat black-
bottom 96-well microtitre plates (Greiner, Austria). The fluorescence polarization
data were fitted with Dynafit59 according to an equilibrium competition
mechanism, with the total concentrations of FimHL, GN-FP-4 and HM (variable)
and the respective Kd of GN-FP-4 (Table 2) as input, and Kd of HM and the
fluorescence polarization at zero and infinite HM concentration as open
parameters.
Crystallization of FimH variants. All crystallization experiments were performed
at 4 C with the sitting drop vapour diffusion method. For crystallization,
FimHF18 DsG and FimHK12 DsG (0.1 0.2 ml, 15mgml 1 in H2O) was mixed
with 0.1 0.2 ml of precipitant (25% (w/v) polyethylene glycol (PEG) 3350, 0.2M
magnesium chloride, 0.1M BisTris-HCl pH 5.5 at 4 C. Crystals of FimHF18 DsG
and FimHK12 DsG grew within 4 6 weeks and are of the space group C2, with
one molecule per asymmetric unit. FimHK12 DsG crystals in space group P1 grew
at 0.2M Na Malonate, 20% PEG3350 within 2 months at 4 C. For crystallization of
the FimHF18 DsG HM complex, a threefold excess over FimH DsG was used
(protein concentration and protein/precipitant ratios were as described for
FimH DsG). Crystals of the space group P213 appeared after 1 month in 30% (v/v)
2-Methyl-2,4-pentanediol, 0.1M sodium cacodylate, 0.2M magnesium acetate pH
6.5 at 4 C. FimHK12 DsF HM crystals appeared after 2 months in 30% w/v PEG
5000, 0.1M 2-(N-morpholino)ethanesulfonic acid (MES) monohydrate, 0.2M
ammonium sulfate pH 6.5 at 20 C (2.5-fold excess of ligand over protein).
FimHLF18 HM crystallized in 17% PEG 2000 MME, 0.1M HEPES–NaOH pH 7.5 at
4 C. FimHLK12 HM crystallized in 1.5M (NH4)2SO4, 0.2M Na acetate pH 5.5 at
20 C.
Crystallographic data collection. All crystals, except for FimHF18 DsG HM,
were cryo-preserved by the addition of ethane-1,2-diol to a final concentration
of 20% (v/v). The precipitant solution used for the crystallization of
FimHF18 DsG HM already contained 30% (v/v) methyl-2,4-pentanediol,
which acts as cryoprotectant. Crystals were flash-cooled in liquid nitrogen. All
measurements were carried out at the SLS beamline X06DA and X06SA (Swiss
Light Source, Paul Scherrer Institute, Switzerland) at 100K. All data were
integrated, indexed and scaled using the XDS software package60 (5% of the
reflections were set aside as test set). Data collection statistics are summarized
in Table 1.
Crystallographic structure determination. All structures were solved by
molecular replacement using structures of isolated FimHL (AA1-158, PDB ID:
3MCY18, and the pilin domain of FimC  FimH (AA160-297, PDB ID: 1QUN24,
as search models with the programme Phaser61). Model building and structure
refinement were performed with Coot (ref. 62) and PHENIX (ref. 63). Twelve out
of thirteen residues could be built for the FimG donor strands in the crystal
structures, and only the C-terminal lysine residue had weak electron density.
Refinement statistics are summarized in Table 1.
Molecular dynamics simulations. Four molecular systems were prepared
for FimHF18. The first system was constructed using the Abound state of
FimHF18 DsG HM (Supplementary Fig. 3a,b) and the second system is equivalent
but HM was removed (Supplementary Fig. 3c,d). The third system contains only
the FimHL and HM from the Abound X-ray structure (Supplementary Fig. 3e,f). The
fourth system was prepared for FimHL and HM based on the Sbound state in the
FimHK12 DsF HM crystal structure (Supplementary Fig. 3g,h).
The CHARMM-GUI web server64 was used to prepare the molecular systems,
which were solvated with TIP3 water molecules and ionized with 50mM NaCl.
Each system contains between 50,000 and 60,000 atoms. All simulations were
performed with the NAMD simulation package (version 2.9) (ref. 65). The
CHARMM36 force field was used for the protein, and parameters for HM were
generated using the CHARMM General Force Field programme (version 0.9.7
beta). Electrostatic interactions were calculated using the particle-mesh Ewald
method66 with a grid spacing of 1 Å. The cutoff for the van der Waals interactions
was taken at 12 Å with a switching function used after 10 Å. Time step for the
integration of dynamics was 2 fs. Simulations were performed in an isothermal–
isobaric ensemble, with a pressure of 1 atm and a temperature of 300 K.
Cell tracking on mannose–BSA-coated surfaces. The E. coli KB18 strain67
was kindly provided by Professor Evgeni Sokurenko and served as host for the
generation of recombinant strains. KB18 contains the pPKL114 plasmid57, which
encodes the whole fim operon with a translational stop linker upstream of the fimH
gene. KB18 was co-transformed with the pGB2-24 plasmid, which was isolated
from the ELT115 strain and encodes fimHJ96 (kindly provided by Professor Evgeni
Sokurenko). Single-nucleotide point mutations were introduced in fimHJ96 using
overlap extension PCR following standard molecular techniques to obtain fimHF18
and fimHF18-Ala188Asp. The PCR products were cloned into pGB2-24 by the
ApaLI and SphI sites, and KB18 was transformed with the resulting plasmid.
E. coli strains were grown from frozen stocks in LB medium supplemented with
antibiotics (100 mgml 1 ampicillin and 25 mgml 1 chloramphenicol) until late
log phase (OD600 of 1.0–1.2) and diluted to an OD600 of 0.01 before movie
acquisition.
Cell culture dishes (35mm, Corning Inc., Corning, NY) were incubated with
50 ml of 50 mgml 1 1M-BSA in 0.02M bicarbonate buffer for 75min at 37 C. The
dishes were then washed three times and quenched with 0.1% PBS–BSA to remove
unbound 1M-BSA and block remaining sites on the plastic surface to prevent
nonspecific binding of bacteria. Controls were prepared by treating cell culture
dishes with 0.1% PBS–BSA only. The bacterial suspension was added to the cell
culture dishes for microscopy studies.
Cell tracking was carried out at room temperature under static conditions.
A bacterial suspension of 50ml in the late logarithmic growth phase was placed
onto the cell culture dishes (diluted to OD600 of 0.01), and a cover slide was placed
on top. The delay between sample placement and start of the movie acquisition was
about 1min. Time-lapse movies were recorded with a  20 phase contrast
objective using a CMOS digital camera (The Imaging Source Europe, Bremen,
Germany) mounted on a Nikon Ti Eclipse inverted microscope and using the NIS
Elements Basic Research software (Nikon, Zurich, Switzerland). Phase contrast
images in an B5-mm-thick surface layer were taken at four to five frames
per second over 5min. The dead time of movie acquisition was B1min. The
resulting images were segmented by creating a projection of the average intensities
over all frames to remove the background and by subsequent thresholding using
the Maximum Entropy method in Fiji68 to obtain binary images (examples shown
in Supplementary Movies 1 and 2). The segmented movies were imported into
Imaris (Bitplane, Zurich, Switzerland) and tracked through the autoregressive
algorithm. A time filter was applied to exclude all tracks with a length below 15 s.
Tracks longer than 15 s were reviewed individually and edited manually, if
necessary. Five to seven independent movies were recorded for each experimental
set-up: FimHF18 or FimHF18-Ala188Asp on 1M-BSA-coated dishes and FimHF18
and FimHF18-Ala188Asp on BSA-coated cell culture dishes. E. coli piliated with
FimHF18 or FimHF18-Ala188Asp binding to 1M-BSA in the absence (1,815 and
1,283 individual tracks, respectively) and in the presence of 200 mMHM (1,175 and
1,071 individual tracks, respectively) were analysed respectively. For E. coli piliated
with FimHF18 or FimHF18-Ala188Asp binding to BSA 1,314 and 1,065 individual
tracks, respectively, were analysed. Bacteria with a speed of o0.5 mms 1 were
classified as attached, all other bacteria were classified as mobile. Owing to
limitation in the spatial and temporal resolution of movie acquisition, we did not
further subdivide bacterial swimming into motility behaviours as ‘rolling’29,53,
‘roaming’, ‘orbiting’ and so on. The individual cell tracks were classified into four
classes: no motility change during observation (pre-attached or mobile), transient
attachment, permanent attachment and permanent detachment. For FimHF18 on
1M-BSA surfaces, 13.9% (251 out of 1,815 tracks) of all tracks showed a single
transient attachment event (Supplementary Fig. 7d). In total, 67 out of the 251
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bacteria that underwent a first transient adhesion attached and detached from the
surface a second time. For these cells, the average time between detachment and
re-attachment was only 13.5 s (Supplementary Fig. 7e), suggesting that re-binding
may be favoured by proximity to the surface as compared with the initial
attachment. The mean velocity on 1M-BSA, as compared with BSA-coated
surfaces, was reduced for both FimHF18-piliated (4.2 and 7.4 mms 1, respectively)
and FimHF18–Ala188Asp-piliated bacteria (3.5 and 8.1 mms 1, respectively;
Supplementary Fig. 7a,b). This reduction of the mean velocity originates from two
different phenomena: in FimHF18-piliated cells it is caused by a change from fast
swimming to a slower mode of motion (Supplementary Fig. 7b; Supplementary
Movie 1), which is consistent with bacterial surface rolling due to weak, short-lived
mannose-based interactions29,53. In contrast, for FimHF18–Ala188Asp-piliated
bacteria, the reduction of the mean velocity results from an increase in the fraction
of adherent cells on 1M-BSA compared with BSA (see main text). In the presence
of 200 mM HM, the mean velocity on 1M-BSA is increased for both FimHF18-
piliated (6.5 mms 1) and FimHF18–Ala188Asp-piliated bacteria (5.9 mms 1;
Supplementary Fig. 7a) and transient and permanent attachment is reduced by
75% and 85%, respectively (Fig. 6 and Supplementary Fig. 7c).
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